Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Title:Patent Selections:
Volume: 9 Issue: 2
Export Options
About this article
Cite this article as:
Patent Selections:, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2015; 9 (2) . https://dx.doi.org/10.2174/187221480902151221161424
DOI https://dx.doi.org/10.2174/187221480902151221161424 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
19
Related Articles
-
Obesity and Diabetes Gene Discovery Approaches
Current Pharmaceutical Design Vascular Disease and Risk Factors in Chronic Kidney Disease
Vascular Disease Prevention (Discontinued) Streptozotocin-Induced Diabetes Mellitus in Neonatal Rats: An Insight into its Applications to Induce Diabetic Complications
Current Diabetes Reviews Biology and Therapeutic Applications of Peroxisome Proliferator- Activated Receptors
Current Topics in Medicinal Chemistry Effective Management of the Type 2 Diabetes Patient with Cardiovascular and Renal Disease: Secondary Prevention Strategies after a Myocardial Infarction
Current Diabetes Reviews Tankyrase as a Novel Molecular Target in Cancer and Fibrotic Diseases
Current Drug Targets Glomerular Endothelium and its Impact on Glomerular Filtration Barrier in Diabetes: Are the Gaps Still Illusive?
Current Medicinal Chemistry Microvascular Complications of Type 2 Diabetes Mellitus
Current Vascular Pharmacology Selenium Compounds Biotransformed by Mushrooms: Not Only Dietary Sources, But Also Toxicity Mediators
Current Nutrition & Food Science Bone Marrow Microenvironment: A Newly Recognized Target for Diabetes- Induced Cellular Damage
Endocrine, Metabolic & Immune Disorders - Drug Targets Epidemiology and Costs of Hypertension-related Disorders
Current Pharmaceutical Design α-Glucosidase Inhibitory Effect and Antioxidant Activity of the Extracts of Eighteen Plant Traditionally Used in Algeria for Diabetes
Current Enzyme Inhibition Towards Standardized Stem Cell Therapy in Type 2 Diabetes Mellitus: A Systematic Review
Current Stem Cell Research & Therapy Targeting the MCP-1/CCR2 System in Diabetic Kidney Disease
Current Vascular Pharmacology Targeting the NLRP3 Inflammasome in Diabetic Nephropathy
Current Medicinal Chemistry Quantitative Structure-Activity Relationship Study of Aromatic Inhibitors Against Rat Lens Aldose Reductase Activity Using Variable Selections
Medicinal Chemistry Seaweed Polysaccharides - New Therapeutic Insights Against the Inflammatory Response in Diabetic Nephropathy
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Erythropoietin Employs Cell Longevity Pathways of SIRT1 to Foster Endothelial Vascular Integrity During Oxidant Stress
Current Neurovascular Research Targeting ADAM17 Sheddase Activity in Cancer
Current Drug Targets Vitamin D Insufficiency and Diabetes Risks
Current Drug Targets